MARC보기
LDR02294nmm uu200433 4500
001000000332739
00520240805171509
008181129s2018 |||||||||||||||||c||eng d
020 ▼a 9780438116207
035 ▼a (MiAaPQ)AAI10811362
035 ▼a (MiAaPQ)northwestern:14097
040 ▼a MiAaPQ ▼c MiAaPQ ▼d 248032
0820 ▼a 574
1001 ▼a Plebanek, Michael Paul.
24510 ▼a Manipulating Exosome Signaling to Inhibit Tumor Metastasis.
260 ▼a [S.l.] : ▼b Northwestern University., ▼c 2018
260 1 ▼a Ann Arbor : ▼b ProQuest Dissertations & Theses, ▼c 2018
300 ▼a 161 p.
500 ▼a Source: Dissertation Abstracts International, Volume: 79-11(E), Section: B.
500 ▼a Advisers: Colby S. Thaxton
5021 ▼a Thesis (Ph.D.)--Northwestern University, 2018.
520 ▼a Over the past decade significant advancements have been made across the field of cancer biology resulting in transformative new therapies. Despite these advancements, treatments for metastatic cancer remain relatively ineffective. Metastasis is
520 ▼a In this project, we were first interested in understanding the effects of exosomes released from non-metastatic cancer cells. It is well established that exosomes from aggressive cancer cells promote metastasis, but the functions of non-aggressi
520 ▼a Additionally, due to the metastasis promoting functions of tumor exosomes, we were interested in developing a technology to specifically inhibit the uptake of cancer exosomes by target cells. Exosome uptake is dependent on cholesterol-rich lipid
520 ▼a The development of HDL NPs led us to test their efficacy as a cancer therapeutic in a wide array of applications. We discovered that HDL NPs can function to inhibit metastasis independent of inhibiting exosome uptake, as well. Myeloid-derived su
590 ▼a School code: 0163.
650 4 ▼a Biology.
650 4 ▼a Oncology.
690 ▼a 0306
690 ▼a 0992
71020 ▼a Northwestern University. ▼b Life Sciences.
7730 ▼t Dissertation Abstracts International ▼g 79-11B(E).
773 ▼t Dissertation Abstract International
790 ▼a 0163
791 ▼a Ph.D.
792 ▼a 2018
793 ▼a English
85640 ▼u http://www.riss.kr/pdu/ddodLink.do?id=T14997975 ▼n KERIS
980 ▼a 201812 ▼f 2019
990 ▼a 관리자